Curiosity is at the core of Biolumina and is the driving force behind the success the agency continues to achieve for their brands, clients, and their employees. According to its leaders, the agency believes that the quest to better understand and seek out new perspectives is essential in today’s constantly changing environment of technology and healthcare.

2017 was a year of transformational change, according to the leaders of The Bloc.

The BlocPartners is the strongest network of leading independent health creative agencies worldwide, with the breadth and depth to build customized solutions – be they global, regional or local, according to network leaders.

BullsEye Healthcare LLC celebrates its eleventh year in business this year. Agency leaders say they are proud that the agency remains an independent, full-service communication company that focuses on finding insights and ideas and providing innovative strategic thinking for its clients.

For Calcium, 2017 was another exciting year of growth, according to agency leaders. “We thought it would be impossible to top the growth we had in 2016,” executives say. “However, Calcium continued to thrive.” The agency ended 2017 with 50 percent revenue growth.

Throughout 2017, Carling Communications took several remarkable steps toward expanding its global footprint, according to its leaders.

According to CDM executives, 2017 was a year in which one of the biggest agency brands in healthcare made some big moves.

Cello Health continues to focus on US expansion via acquisitions and also through substantial organic growth in both the talent base and service offerings during 2017.

Simply Thrive: it’s more than a tagline, or an agency positioning. According to Centron’s leaders, it is a philosophy that has shaped the transformation of the agency into an “open destination” with a singular purpose: to find the simplest path to the highest good for clients, brands, and the communities they serve.

According to the leaders of closerlook inc., the pharmaceutical industry is changing yet again. These executives say a flood of announced mergers and acquisitions is creating powerful therapeutic franchises. New scientific breakthroughs are accelerating the development of therapies that can cure – not just manage – chronic conditions and diseases. Biotech startups are bringing exciting new innovations to market. CEOs are rethinking their path to scale. And companies are testing new strategies for managing and growing their portfolios.